CMV prophylaxis: a useful step towards prevention of post-transplant diabetes? R. M. Smith Commentary 25 August 2004 Pages: 1473 - 1475
What can the HLA transgenic mouse tell us about autoimmune diabetes? F. S. WongL. Wen Review 02 September 2004 Pages: 1476 - 1487
Vascular calcification and osteolysis in diabetic neuropathy—is RANK-L the missing link? W. Jeffcoate For Debate 21 August 2004 Pages: 1488 - 1492
Maternal dietary vitamin restriction increases body fat content but not insulin resistance in WNIN rat offspring up to 6 months of age L. VenuN. HarishankarM. Raghunath Article 10 September 2004 Pages: 1493 - 1501
The role of the p75 neurotrophin receptor in the morphology of dorsal root ganglion cells in streptozotocin diabetic mice: effects of sciatic nerve crush Y. JiangJ. Jakobsen Article 09 September 2004 Pages: 1502 - 1510
Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality G. BertonR. CordianoP. Palatini Article 18 August 2004 Pages: 1511 - 1518
Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial The DREAM Trial Investigators Article 21 August 2004 Pages: 1519 - 1527
Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients G. N. ThomasJ. W. LinK. S. Wong Article 25 August 2004 Pages: 1528 - 1534
Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients A. CerielloR. AssaloniD. Giugliano Article 14 August 2004 Pages: 1535 - 1540
Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes P. WeiP. H. LaneS. C. Sansom Article 27 August 2004 Pages: 1541 - 1549
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation J. HjelmesæthS. SagedalT. Jenssen Article 27 August 2004 Pages: 1550 - 1556
Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease S. G. WannametheeG. D. O. LoweP. H. Whincup Article 09 September 2004 Pages: 1557 - 1565
Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms J. O. ChristensenA. SandbækK. Borch-Johnsen Article 08 September 2004 Pages: 1566 - 1573
Association between the A–2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus E. SimeoniM. M. HoffmannG. Vassalli Article 02 September 2004 Pages: 1574 - 1580
Conformation-dependent GAD65 autoantibodies in diabetes D. LuoL. K. GilliamÅ. Lernmark Article 08 September 2004 Pages: 1581 - 1591
Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells F. ReimannL. WilliamsF. M. Gribble Article 09 September 2004 Pages: 1592 - 1601
Metabolic adaptations to chronic glucose infusion in rats B. G. ToppM. D. McArthurD. T. Finegood Article 02 September 2004 Pages: 1602 - 1610
Expression of uncoupling protein-3 mRNA in rat skeletal muscle is acutely stimulated by thiazolidinediones: an exercise-like effect? B. BrunmairF. GrasC. Fürnsinn Short Communication 02 September 2004 Pages: 1611 - 1614
Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-α induction of p38 and p42/p44 mitogen-activated protein kinases R. HernandezT. TeruelM. Lorenzo Article 09 September 2004 Pages: 1615 - 1624
Biological correlates of day-to-day variation in flow-mediated dilation in individuals with Type 2 diabetes: a study of test–retest reliability S. G. WestP. WagnerA. L. Hinderliter Article 09 September 2004 Pages: 1625 - 1631
The Pal elements in the upstream glucokinase promoter exhibit dyad symmetry and display cell-specific enhancer activity when multimerised J. M. MoatesM. A. Magnuson Article 10 September 2004 Pages: 1632 - 1640
MHC class II expression by beta cells in Type 1 diabetes: promoting or inhibiting the autoimmune process? A reply to D. W. R. Gray U. WalterW. A. ScherbaumJ. Buer Author’s Reply 18 August 2004 Pages: 1641 - 1642
re: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31–39 A. B. JenkinsS. M. FurlerL. V. Campbell Comment 18 August 2004 Pages: 1642 - 1643
Reply to Comment on: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 43:31–39 A. GastaldelliE. FerranniniR. A. DeFronzo Authors’ Reply 18 August 2004 Pages: 1643 - 1644
R. Hanas (2002) Type 1 Diabetes in children, adolescents and young adults. How to become an expert on your own diabetes. Second edition. Class Publishing, London, UK. (ISBN 1 85959 078 0) Book reviews 24 September 2004 Pages: 1645 - 1645